|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Heart, Lung, and Blood Institute (NHLBI) |
|---|---|
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00106327 |
Purpose
The purpose of this study is to compare the effects of nutrition, a supervised treadmill exercise program, and supervised progressive resistance training program on peripheral arterial disease.
| Condition | Intervention |
|---|---|
|
Cardiovascular Diseases Peripheral Vascular Diseases |
Behavioral: Exercise Behavioral: Diet |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Single Blind (Outcomes Assessor), Parallel Assignment |
| Official Title: | Improving Functioning in Peripheral Arterial Disease |
| Estimated Enrollment: | 150 |
| Study Start Date: | September 2003 |
| Study Completion Date: | March 2009 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: Experimental
6-month supervised treadmill exercise program
|
Behavioral: Exercise
6 months of supervised treadmill exercise or strength training, three times per week, followed by a 6 month home-based program.
|
|
2: Experimental
6-month supervised lower extremity progressive resistance training program
|
Behavioral: Exercise
6 months of supervised treadmill exercise or strength training, three times per week, followed by a 6 month home-based program.
|
|
3: Active Comparator
Diet/nutrition control group
|
Behavioral: Diet
11 nutrition education sessions
|
BACKGROUND:
Previous work demonstrates that functional limitations associated with peripheral arterial disease (PAD) are diverse and include slower walking speed, poorer walking endurance, and impaired balance as compared to persons without PAD. Although treadmill-walking exercise improves treadmill performance in patients with intermittent claudication (IC), treadmill performance does not correlate well with community walking ability in older men and women. In older patient populations without PAD, resistance training improves functioning and walking endurance, but this mode of exercise has not been sufficiently studied in PAD. Furthermore, although 65% to 70% of men and women with PAD are either asymptomatic or have exertional leg symptoms other than IC, no prior studies have assessed the effects of exercise interventions in PAD patients who do not have IC.
DESIGN NARRATIVE:
The randomized, control study will determine whether a 6-month supervised treadmill exercise program and a supervised lower extremity progressive resistance training program, respectively, improve lower extremity functioning compared to a nutrition control group among 150 PAD patients with and without IC. The investigators hypothesize that participants in the treadmill walking exercise program and participants in the progressive resistance training program, respectively, will experience greater improvement in functional outcomes than participants in the nutrition control group. The primary functional outcome measures in descending order of importance are 6-minute walk distance and the summary performance score. The summary performance score is a composite measure of lower extremity functioning (usual walking speed, standing balance, and time required for five repeated chair rises) measured on a 0-12 scale that predicts future risk of nursing home placement, mobility loss, and mortality. The study will also identify mechanisms by which the exercise interventions improve functioning in PAD. Mechanisms to be studied include changes in blood viscosity, calf blood flow, brachial artery endothelial reactivity, and inflammatory cytokine levels. By identifying the optimal exercise program for improving functioning in PAD patients with and without IC, the findings will have substantial clinical and public health implications for millions of patients with PAD.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Illinois | |
| Northwestern University Feinberg School of Medicine | |
| Chicago, Illinois, United States, 60611-3008 | |
| Principal Investigator: | Mary McDermott, MD | Northwestern University Feinberg School of Medicine |
More Information
| Responsible Party: | Northwestern University ( Mary McDermott, MD ) |
| Study ID Numbers: | 171, R01 HL073351 |
| Study First Received: | March 22, 2005 |
| Last Updated: | April 17, 2009 |
| ClinicalTrials.gov Identifier: | NCT00106327 History of Changes |
| Health Authority: | United States: Federal Government |
|
Peripheral Vascular Diseases Vascular Diseases Cardiovascular Diseases |